Description

Diabetes is one of the top 10 causes of death globally. It causes distress, disability, and premature death. A diabetic person experiences high glucose level in their blood, either because the beta cells do not produce insulin (Type 1 diabetes) that is required for the breakdown of glucose, or because the insulin produced is not utilized properly (Type 2 diabetes). The global continuous glucose monitoring market is set to grow by US$ 3 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 14.6% during the forecast period, according to data and analytics company StrategyHelix. Rise in incidence of diabetes cases, government support initiatives to constrict the spread of diabetes and increasing obesity population are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for continuous glucose monitoring. The global continuous glucose monitoring market is segmented on the basis of component, demographics, end user, and region. By component, it is categorized into sensors, and durables (receivers and transmitter). The sensors segment held the largest market share in 2020. By demographics, the continuous glucose monitoring market is divided into child population (≤14 years), and adult population (>14 years). The adult population (>14 years) segment accounted for the largest market share in 2020. Based on end user, the continuous glucose monitoring market is divided into diagnostics/clinics, ICUs, and home healthcare.

The report has profiled some of the key players of the market such as A. Menarini Diagnostics S.r.l., Abbott Laboratories, Dexcom Inc., Echo Therapeutics Inc., GlySens Incorporated, Insulet Corporation, LifeScan Inc., Medtronic MiniMed Inc, Roche Diabetes Care GmbH, Senseonics Holdings Inc..

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the continuous glucose monitoring market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Component: sensors, and durables (receivers and transmitter)
Demographics: child population (≤14 years), and adult population (>14 years)
End user: diagnostics/clinics, ICUs, and home healthcare
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders

Get a comprehensive picture of the global continuous glucose monitoring market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Pinpoint growth sectors and trends for investment
Understand what the future of the global continuous glucose monitoring market looks like
Identify the competitive landscape and window of opportunity

Table of Contents

1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Continuous Glucose Monitoring Market by Component
4.1 Sensors
4.2 Durables (Receivers And Transmitter)
5. Continuous Glucose Monitoring Market by Demographics
5.1 Child Population (≤14 Years)
5.2 Adult Population (>14 Years)
6. Continuous Glucose Monitoring Market by End User
6.1 Diagnostics/Clinics
6.2 Icus
6.3 Home Healthcare
7. Continuous Glucose Monitoring Market by Region
7.1 North America
7.2 Asia Pacific
7.3 Europe
7.4 Rest Of The World (Row)
8. Company Profiles
8.1 A. Menarini Diagnostics S.r.l.
8.2 Abbott Laboratories
8.3 Dexcom Inc.
8.4 Echo Therapeutics, Inc.
8.5 GlySens Incorporated
8.6 Insulet Corporation
8.7 LifeScan, Inc.
8.8 Medtronic MiniMed Inc
8.9 Roche Diabetes Care GmbH
8.10 Senseonics Holdings, Inc.
9. Appendix
9.1 About StrategyHelix
9.2 Disclaimer